Activity of nacubactam (RG6080/OP0595) combinations against MBL-producing Enterobacteriaceae

Abstract

Nacubactam combinations, including those using MBL-labile β-lactams, e.g. meropenem and cefepime, can overcome most MBL-mediated resistance. This behaviour reflects nacubactam's direct antibacterial and enhancer activity.